USA Warehouse 7,8-Dhf Price CAS 38183 -03-8/Nsi-189 CAS 1270138-40-3/Nsi-189 Phosphate CAS 1270138-41-4/CAS 367514-88-3 Lurasidone HCl/CAS 22503-72-6 and Idra-21

China USA Warehouse 7,8-Dhf Price CAS 38183-03-8/Nsi-189 CAS 1270138-40-3/Nsi-189 Phosphate CAS 1270138-41-4/CAS 367514-88-3 Lurasidone HCl/CAS 22503-72-6 and Idra-21, Find details about China 7 8-Dhf, 7 8-Dhf Price from USA Warehouse 7,8-Dhf Price CAS 38183-03-8/Nsi-189 CAS 1270138-40-3/Nsi-189 Phosphate CAS 1270138-41-4/CAS 367514-88-3 Lurasidone HCl/CAS 22503-72-6 and Idra-21

Basic Info.

Model NO.

Idra-21

CAS

22503-72-6

C8h9cln2o2s

232.69

Appearance

White Powder

Function

Biological and Pharmaceutical Intermediates

Shelf Life

2 Years

Test Method

HPLC UV

Storage

Cool Dry Place

Payment

Tt.Western Union .Credit Card.Moneygram

Delivery Time

Within 2 Days

Certificate

COA MSDS

Sample

Available

Trademark

Faithful

Transport Package

Aluminum Foil Bag Packaging

Specification

10g/bag; 100g/bag; 1kg/bag

Origin

China

Model NO.

Idra-21

CAS

22503-72-6

C8h9cln2o2s

232.69

Appearance

White Powder

Function

Biological and Pharmaceutical Intermediates

Shelf Life

2 Years

Test Method

HPLC UV

Storage

Cool Dry Place

Payment

Tt.Western Union .Credit Card.Moneygram

Delivery Time

Within 2 Days

Certificate

COA MSDS

Sample

Available

Trademark

Faithful

Transport Package

Aluminum Foil Bag Packaging

Specification

10g/bag; 100g/bag; 1kg/bag

Origin

China

Product Desciption

USA Warehouse 7,8-Dhf price CAS 38183-03-8/Nsi-189 CAS 1270138-40-3/Nsi-189 Phosphate CAS 1270138-41-4/CAS 367514-88-3 Lurasidone hcl/CAS 22503-72-6 and Idra-21

Introduction

Product Name	IDRA-21
CAS NO.	22503-72-6
MF	C8H9ClN2O2S
MW	232.687
Appearance	White Powder
Purity	99% min
Density	1.4±0.1 g/cm3
Boiling point	405.1±55.0 °C at 760 mmHg

IDRA-21 is a relatively new nootropic compound. It works as an ampakine stimulant drug and is currently being researched in regards to its effects in memory improvement, cognitive enhancement, stimulation, and reversing cognitive deficits. It's likely it was developed in 1994 or 1995 as the first clinical trials and peer-reviewed research articles appear in the literature in 1995.
Function

1)Increases in cognition

2)Increased Task Accuracy

3)Increases in Short Term Memory

4)Potential Therapeutic Effects On Schizophrenia

5)Potential Therapeutic Effects On Depression

6)Neuroprotection

Specification

Product name	IDRA-21
CAS No.	22503-72-6	Outer Packing	1KG/bag
Production date	15th Jan 2019	Shelf life	14th Jan 2021
Standard adopted	Enterprise standard
Analysis Test	Specification		Result
Description	White to off white powders		Complies
Identification	IR: The infra red absorption spectrum of the sample should be similar to the IR absorption spectrum of IDRA-21 working standard.		Complies
Assay	≥99.0%		99.57%
Solution clarity and color	solution should be clear and colorless		Conforms
Loss on drying	≤0.5%		0.11%
Residue on ignition	≤0.1%		0.04%
Heavy mentals	≤20ppm		≤
Chromatographic purity (HPLC)	Max single impurity: ≤0.5% Total impurities: ≤1.0%		0.02% 0.07%